Delivery Order SPE2DB22D3102-SPE2DB25FK9TZ

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of Levothyroxine 100 MCG Vials, a pharmaceutical product. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,797.52. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 21, 2025. The contract does not have a set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,549.20 firm fixed-price contract is for the supply of 4567115093 LEVOTHYROXINE 100 MCG VIALS, a critical pharmaceutical product, with a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of 1,000 tablets of the pharmaceutical product levothyroxine 112 mcg to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, as a firm fixed-price delivery order. The potential value of the contract is $1,092.69, and the delivery is expected to be completed by December 28, 2023. No set-aside designation was used...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,945.20 for the supply of 4,564,085,692 units of 100 mcg/5 ml vial of levothyroxine. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and also holds an Indefinite Delivery Contract (IDC) with DLA valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Levothyroxine 25 mcg capsules. The contract has a ceiling value of $1,230.19 and is set to run through August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,271.49 Firm Fixed Price Delivery Order is for the supply of 4564435293 - Levothyroxine 100 MCG Vials. The contract does not have a set-aside designation and has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This federal contract award, valued at $1,586.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Synthroid 100 mcg tablets, a common thyroid medication, with a period of performance through July 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Synthroid (levothyroxine sodium) 50 mcg tablets. The $2,530.39 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of Synthroid 25 MCG tablets in 1,000 count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. This is a firm fixed-price delivery order contract with a ceiling value of $1,462.38 and a completion date of May 14, 2024. The contract is not a set-aside award....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,273.31, is for the delivery of 4,567,154,037 units of Levothyroxine 150 MCG Capsule 30S, a medication used to treat hypothyroidism. The contract has a Firm Fixed Price pricing type and a completion date of February 5, 2025. This appears to be a task order under a larger Indefinite...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9TZ
    Delivery Order

This federal contract award SPE2DB22D3102|SPE2DB25FK9TZ, valued at $1,214.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567090510 - LEVOTHYROXINE 50 MCG TABLET 1000S and has an ultimate completion date of January 30, 2025. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/30/25, 10:07 AM